Skip to content

A study to compare Indian heart failure patients with and without diabetes

Study of clinical characteristics and management of Indian outpatients of chronic heart failure with coexistent diabetes versus those without diabetes (HF-DIAB) - HF-DIAB

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/07/009069
Enrollment
2500
Registered
2017-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Heart failure with and without diabetes

Interventions

None listed

Sponsors

Cipla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult ambulant outpatients of both genders diagnosed with chronic heart failure, based on standard clinical criteria and clinical judgement of the treating physician, with stable clinical signs and symptoms of heart failure for at least 3 months 2. Presence or absence of diabetes will be based on whether or not the patient has been diagnosed with diabetes prior to study entry. If diabetes is present, patient will be included only if he has had a history of diabetes for at least 6 months 3. A written, signed and dated data sharing consent from all participants before start of survey procedures

Exclusion criteria

Exclusion criteria: 1. Hospitalized patients of heart failure 2. Heart failure patients of the following etiologies - a. congenital heart disease b. valvular heart disease c. cor-pulmonale, including primary pulmonary hypertension

Design outcomes

Primary

MeasureTime frame
Difference in the percentage of patients receiving RAAS blockers and beta-blockers in heart failure with coexistent diabetes group vs heart failure without diabetes groupTimepoint: Single visit

Secondary

MeasureTime frame
Difference in treatment of heart failure between cardiologist and internistTimepoint: Single visit;Differences in age, gender, BMI, blood pressure, symptoms, signs, heart failure etiology, ejection fraction, heart failure hospitalizations, NHYA class, drugs prescribed for heart failure (ACEI, ARB, beta-blocker, diuretics, MRA, ivabradine, hydralazine/isosorbide dinitrate, omega-3 polyunsaturated fatty acid), interventional procedures, heart failure devices, comorbidities in the heart failure with diabetes group vs heart failure without diabetes groupTimepoint: Single visit

Countries

India

Contacts

Public ContactMeena Lopez

Cipla Ltd

meena@cipla.com9820515620

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 25, 2026